Authors:
Wanebo, H
Chougule, P
Ready, N
Safran, H
Ackerley, W
Koness, RJ
McRae, R
Nigri, P
Leone, L
Radie-Keane, K
Reiss, P
Kennedy, T
Citation: H. Wanebo et al., Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer ofthe head and neck (stage III and IV), ANN SURG O, 8(8), 2001, pp. 644-650
Authors:
Safran, H
Moore, T
Iannitti, D
Dipetrillo, T
Akerman, P
Cioffi, W
Harrington, D
Quirk, D
Rathore, R
Cruff, D
Vakharia, J
Vora, S
Savarese, D
Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation for locally advanced pancreatic cancer, INT J RAD O, 49(5), 2001, pp. 1275-1279
Authors:
Safran, H
Steinhoff, M
Mangray, S
Rathore, R
King, TC
Chai, L
Berzein, K
Moore, T
Iannitti, D
Reiss, P
Pasquariello, T
Akerman, P
Quirk, D
Mass, R
Goldstein, L
Tantravahi, U
Citation: H. Safran et al., Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma, AM J CL ONC, 24(5), 2001, pp. 496-499
Authors:
King, TC
Akerley, W
Fan, AC
Moore, T
Mangray, S
Chen, MH
Safran, H
Citation: Tc. King et al., p53 mutations do not predict response to paclitaxel in metastatic nonsmallcell lung carcinoma, CANCER, 89(4), 2000, pp. 769-773
Citation: Tc. King et al., Role of p53 and p16 gene alterations in determining response to concurrentpaclitaxel and radiation in solid tumors, SEM RAD ONC, 9(2), 1999, pp. 4-11
Authors:
Safran, H
Akerman, P
Cioffi, W
Gaissert, H
Joseph, P
King, T
Hesketh, PJ
Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction, SEM RAD ONC, 9(2), 1999, pp. 53-57
Authors:
Wanebo, HJ
Chougule, P
Ready, N
Koness, RJ
Akerley, W
McRae, R
Nigri, P
Leone, L
Webber, B
Safran, H
Citation: Hj. Wanebo et al., Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV), SEM RAD ONC, 9(2), 1999, pp. 77-84